Loading…
DexCom, Inc. is projected to rise to $86.68 by 2027, a +16% move from its current price of $74.96. DXCM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $73.49 | $74.97 | $76.47 | +0.01% |
| Jul 14 | $72.90 | $74.97 | $77.11 | +0.02% |
| Jul 15 | $72.44 | $74.98 | $77.61 | +0.03% |
| Jul 16 | $72.06 | $74.99 | $78.03 | +0.04% |
| Jul 17 | $71.73 | $74.99 | $78.40 | +0.04% |
| Jul 18 | $71.44 | $75.00 | $78.74 | +0.05% |
| Jul 19 | $71.16 | $75.01 | $79.06 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $71.16 | $75.01 | $79.06 | +0.06% |
| Week 2 | $69.67 | $75.05 | $80.85 | +0.12% |
| Week 3 | $68.56 | $75.10 | $82.26 | +0.19% |
| Week 4 | $67.65 | $75.15 | $83.48 | +0.25% |
| Week 5 | $66.85 | $75.19 | $84.58 | +0.31% |
| Week 6 | $66.15 | $75.24 | $85.58 | +0.37% |
| Week 7 | $65.51 | $75.29 | $86.52 | +0.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
DexCom, Inc. is a medical device company focused on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated CGM system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application.
It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
DexCom, Inc. trades under the symbol DXCM and is currently priced at $71.23. Its market capitalization is $27.49B and it holds the 480th rank. The near-term forecast shows a neutral stance in 2026 with min $57.56, avg $71.23, max $92.65 and sentiment NEUTRAL, while 2027 remains NEUTRAL and 2028 turns BULLISH with rising price expectations.
A major floor 23.2% below — a decisive break under it would weaken the trend.
The nearest floor, 10.2% below — buyers have tended to step in here.
The nearest ceiling, 4.3% above — a clean break opens room to run.
A major ceiling 12.5% above — clearing it would confirm fresh momentum.
Key DXCM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DXCM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $73.60 | Buy | $73.40 | Buy |
| MA 10 | $71.56 | Buy | $72.44 | Buy |
| MA 20 | $71.68 | Buy | $71.78 | Buy |
| MA 50 | $68.88 | Buy | $70.00 | Buy |
| MA 100 | $67.74 | Buy | $68.85 | Buy |
| MA 200 | $67.15 | Buy | $69.71 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.07 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 101.00 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.28 | Buy |
| ROC (12) | 8.76 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | 1.18 | Buy |
| Ultimate (7,14,28) | 74.50 | Sell |
| Momentum (10) | 6.31 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 75.05 | Sell |
| ADX (14) | 15.66 | Neutral |
| ATR (14) | 1.38 | Info |
The 30-day technical picture leans bullish with RSI(14) at 50. The 50-day simple moving average is $66.47 and the 200-day simple moving average is $67.53. Support is at $57.82 and resistance is at $78.19, defining a 30-day trading range from $61.79 to $82.11.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $57.56 | $74.96 | $97.21 | 0% | Neutral | |
| $70.75 | $86.68 | $111.20 | +16% | Neutral | |
| $75.63 | $94.50 | $124.68 | +26% | Bullish | |
| $79.05 | $100.39 | $135.40 | +34% | Bullish | |
| $93.27 | $120.15 | $165.11 | +60% | Bullish | |
| $107.56 | $140.36 | $196.07 | +87% | Bullish | |
| $115.51 | $152.54 | $216.26 | +104% | Bullish | |
| $125.21 | $167.20 | $240.25 | +123% | Bullish | |
| $129.89 | $175.29 | $255.02 | +134% | Bullish | |
| $134.20 | $182.92 | $269.21 | +144% | Bullish | |
| $199.60 | $284.57 | $439.76 | +280% | Bullish | |
| $350.03 | $537.86 | $893.42 | +618% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $57.56 | $74.96 | $89.98 | +0.00% |
| August 2026 | $65.03 | $76.19 | $91.26 | +1.64% |
| September 2026 | $64.17 | $75.57 | $91.26 | -0.82% |
| October 2026 | $65.42 | $77.38 | $94.10 | +2.39% |
| November 2026 | $66.96 | $79.49 | $97.23 | +2.73% |
| December 2026 | $66.37 | $79.06 | $97.21 | -0.55% |
Click any year to see its month-by-month DXCM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect DXCM to range from $57.56 to $97.21 through 2026. The $74.96 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The DXCM price prediction for 2027 points to an average of $86.68 (low $70.75, high $111.20) — a potential gain of +16% on today's $74.96. Price action looks broadly range-bound.
In 2028, DXCM is projected to trade between $75.63 and $124.68, averaging $94.50 — a potential gain of +26% from today's $74.96. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
DexCom, Inc.'s 2029 outlook centres on $100.39, within a $79.05 to $135.40 range. That is up +6% on the projected 2028 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2030, DXCM could reach as high as $165.11, with a base case around $120.15 and support toward $93.27 — roughly +60% from $74.96. Buyers look set to stay in control over this stretch.
Expect DXCM to range from $107.56 to $196.07 through 2031. The $140.36 average target implies a +87% move from current prices. That is up +17% on the projected 2030 average. Momentum favours further upside here.
The DXCM price prediction for 2032 points to an average of $152.54 (low $115.51, high $216.26) — a potential gain of +104% on today's $74.96. Buyers look set to stay in control over this stretch.
In 2033, DXCM is projected to trade between $125.21 and $240.25, averaging $167.20 — a potential gain of +123% from today's $74.96. That is up +10% on the projected 2032 average. Momentum favours further upside here.
DexCom, Inc.'s 2034 outlook centres on $175.29, within a $129.89 to $255.02 range. That is up +5% on the projected 2033 average. That marks a +134% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, DXCM could reach as high as $269.21, with a base case around $182.92 and support toward $134.20 — roughly +144% from $74.96. Momentum favours further upside here.
Expect DXCM to range from $199.60 to $439.76 through 2040. The $284.57 average target implies a +280% move from current prices. That is up +56% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The DXCM price prediction for 2050 points to an average of $537.86 (low $350.03, high $893.42) — a potential gain of +618% on today's $74.96. Momentum favours further upside here.
Investing $1,000 in DXCM today (≈ 13.340448 DXCM) could be worth
$7,175.31
+$6,175.31 (+618%) by 2050 · US Dollar
Based on the average projected DXCM price of $537.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DXCMwould be worth at today's price.
$1,000 invested in DXCM on Jul 10, 2025 (≈ 11.701381 DXCM) would be worth
$877.14
-$122.86 (-12.3%) today · 0.88× · US Dollar
Based on a DXCM entry price of $85.46 vs. today's $74.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $71.25 | $1,052.07 | +5.2% |
| 1 month ago | $74.77 | $1,002.54 | +0.3% |
| 3 months ago | $64.02 | $1,170.88 | +17.1% |
| 6 months ago | $70.98 | $1,056.07 | +5.6% |
| 1 year ago | $85.46 | $877.14 | -12.3% |
| All time (5.0y) ago | $111.6 | $671.7 | -32.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DXCM forecast.
Our base-case forecast reaches $150.00 around 2032.
Implied market cap at $150.00: $57.88B
The multi-year forecast shows 2026 with min $57.56, avg $71.23, max $92.65 and ROI 0 with sentiment NEUTRAL. It then projects 2027 min $67.29, avg $83.03, max $107.63 with ROI 16.6 and sentiment NEUTRAL; 2028 min $71.11, avg $89.62, max $119.66 with ROI 25.8 and sentiment BULLISH; 2029 min $73.74, avg $94.60, max $129.28 with ROI 32.8 and sentiment BULLISH. By 2030 the forecast shows avg $115.57, min $88.71, max $161.11 with ROI 62.3 and sentiment BULLISH, and by 2031–2050 the path remains bullish with 2031 avg $131.75, 2032 avg $142.18, 2033 avg $160.73, 2034 avg $162.87, 2035 avg $167.98, 2040 avg $262.19, and 2050 avg $499.11 accompanied by higher ROIs (e.g., 85, 99.6, 125.7, 128.7, 135.8, 268.1, 600.7 respectively).
The long horizon carries bullish sentiment across these years, but the data also reflect notable volatility (annualized volatility of 40%). These figures suggest meaningful upside over the long term, while near-term outcomes remain uncertain and not guaranteed.
Tap a question to reveal the answer.
The forecast lists min $88.71, avg $115.57, max $161.11 with ROI 62.3% and sentiment BULLISH.
The forecast shows bullish sentiment in the long term (2030, 2040, 2050) with rising average prices and positive ROIs (e.g., 2030 avg $115.57 with ROI 62.3%; 2040 avg $262.19 with ROI 268.1%; 2050 avg $499.11 with ROI 600.7%), though near-term 2026 is NEUTRAL and results are not guaranteed.
Yes. The maximums in the forecast exceed $200 in several years: 2032 max $204.88; 2033 max $234.94; 2034 max $241.22; 2035 max $251.86; 2040 max $413.99; and 2050 max $850.63.
Market cap is $27.49B and rank is 480.
DexCom, Inc. Community Discussion
0Share your DexCom, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.